Share Name Share Symbol Market Type Share ISIN Share Description
Salvarx Grp LSE:SALV London Ordinary Share IM00BZ4SS228 ORD 2.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 35.25p 35.00p 36.00p - - - 0.00 08:26:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -0.3 -0.1 - 12.85

Salvarx Grp Share Discussion Threads

Showing 76 to 97 of 100 messages
Chat Pages: 4  3  2  1
DateSubjectAuthorDiscuss
06/2/2017
22:44
The price action is very positive. Some people in the know are snapping up the shares in anticipation of good news flow. The share price is likely to move up to a higher range above 40 p soon.
kingston78
03/2/2017
11:37
Profit taking is bound to happen as the anticipated news is not yet announced, but I think the price will move up again to a new height.
kingston78
03/2/2017
08:00
MMs have only marked it down a penny so it will take continuous selling to move the price downwards. I suspect the buyer is still there waiting to see if they can pick up cheap stock. If not, the buying direct from market and AT trades will continue and I suspect we can look forward to an update from the more lucrative iOX instead.
phil1969
03/2/2017
07:52
To be fair they may not have been aware of the moneyweek comment until this week i feel this may hold today, or not fall too sharply
kristini2
03/2/2017
06:58
Only taken them 7 days to release the clarification! Still - changes nothing except timescale, and may even build up a little publicity.
spectoacc
02/2/2017
16:54
02 February 2017 SalvaRx Group plc ("SalvaRx" or "the Company") Intensity Therapeutics Inc. The Company notes the recent article in MoneyWeek Magazine about SalvaRx and Intensity Therapeutics Inc., ("Intensity") in which the Company has an 8.5 per cent. interest. The article incorrectly stated that Intensity had dosed its first patient in clinical trials. Intensity expects to dose its first patient shortly at which point a further notification will be made by SalvaRx which will contain full details of the trial including the timeframe for results.
the stigologist
02/2/2017
16:51
RNS - first patient NOT dosed in clinical trials recently. Appears Moneyweek got it wrong - as have many buyers that have no doubt piled in here upon reading this article!Hopefully this won't have a significant impact on the share price tomorrow...
joemillion
02/2/2017
15:33
News is long overdue. They've so many projects in the pipeline plus possible clinical trial results due mentioned in MoneyWeek interview suggesting only 2-3 weeks before knowing results. Volume increased along with share price on Monday I presume as a result of interview. Then the usual lull. Now we have an order being filled and MM's having to take them off the offer with AT trades. Always a positive sign.
phil1969
02/2/2017
15:26
There must be some good news to be announced soon. I have held onto this share because I had faith in the management and their track record.
kingston78
02/2/2017
14:47
Good place to be Phil.(so far!)Fig.
fig1
02/2/2017
14:46
I'm in :-)
phil1969
02/2/2017
13:31
Holy smoke!!!Fig.
fig1
02/2/2017
12:27
Plenty of buying still going on.Hope the punters aren't let down.Fig.
fig1
01/2/2017
15:13
https://www.youtube.com/watch?v=F3ywIVrJ-S4&app=desktop News coming soon on the first human trial from Intensity Therapeutics - INT230-6. They've fingers in other pies but the corporate presentation from last September is a useful starting point when looking at the co.
spectoacc
30/1/2017
09:37
Positive article in Money Week, round table interview with Jim, first patient dosed with results in 2 weeks. All looking very bright.
joemillion
30/1/2017
09:17
Does anyone know why the share price has gone up? Is there an announcement soon?
kingston78
17/11/2016
13:59
with your reputation Mr Holden it probably isn't a good idea to cast stones.
loveandmoney1
17/11/2016
13:57
He doesn't present any substantive analysis to back up his views, usual shooting from the lip.
the stigologist
17/11/2016
13:23
Sorry do tell, I thought he was a fan.
korvet
17/11/2016
13:23
Did tell Stig
korvet
07/11/2016
10:52
That would be pretty satisfactory.Good luck K.Fig.
fig1
14/10/2016
08:31
Yes, I was kind of thinking a pound within 18mths and all going well 2£ 3 to 5 years as they have at least 2 to 3 projects on the go and an attitude to squire more.
korvet
Chat Pages: 4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170223 09:41:12